Take control of your habit
Habitrol (habitrol.com) scores 81 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 82nd percentile of 20830 Healthcare brands.
Habitrol is a nicotine replacement therapy brand that offers patches, gum, and lozenges designed to help adult smokers in the U.S. manage cravings and quit smoking. The brand is backed by Dr. Reddy's Laboratories and positions itself as a science-based smoking cessation solution offering personalized product options tailored to individual quitting journeys.
| Brand Name | Habitrol |
|---|---|
| Domain | habitrol.com |
| Industry | Healthcare |
| Parent Company / Owner | Dr. Reddy's Laboratories |
| Main Competitors | Nicorette (79/100), NicoDerm CQ (75/100), Nicotrol, Kirkland Signature Nicotine (82/100), Equate Nicotine (72/100) |
Habitrol has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Explore Habitrol nicotine replacement products including gum, lozenges, and patches. Find effective solutions to help manage cravings and support your quit smoking journey." (Meta description: 23 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, Shopify.
Social footprint: verified profiles on X (Twitter), Instagram, Facebook, YouTube; no detected presence on LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked November 2026.
When asked "What is Habitrol?", Claude could identify the brand as of November 2026. Habitrol is a brand of nicotine replacement therapy products, best known for its nicotine transdermal patches used to help people quit smoking. Best known for Nicotine patches for smoking cessation.
When asked "Best brands similar to Habitrol?", Claude would recommend Habitrol as of November 2026. It's a well-established, widely available nicotine patch brand often compared to Nicoderm CQ and other quit-smoking aids.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Habitrol's main competitors in Healthcare: Nicorette (79/100), NicoDerm CQ (75/100), Kirkland Signature Nicotine (82/100), Equate Nicotine (72/100).
Sources: Brand Analyzer scan
Habitrol has limited AI-search visibility, scoring 41/100 on Brand Analyzer's AI visibility composite (visibility 40, trust 28, recommendation 57). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Habitrol official site
Habitrol offers a range of nicotine replacement therapy products, including nicotine patches, nicotine gum, and nicotine lozenges. These products are designed to help manage nicotine cravings for individuals attempting to quit smoking.
Sources: Habitrol official site
Habitrol scores 57/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Habitrol official site
Habitrol is a nicotine replacement therapy (NRT) brand that produces smoking cessation products including nicotine patches, gum, and lozenges. It is backed by Dr. Reddy's Laboratories and is marketed to adult smokers in the U.S. who are seeking to quit or reduce smoking.
Sources: Habitrol official site
Habitrol develops and sells nicotine replacement products-patches, gum, and lozenges-that help people manage nicotine cravings associated with quitting smoking. The products are designed to offer different delivery methods so users can choose an option suited to their individual quitting process.
Sources: Habitrol official site
Habitrol can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Habitrol official site
Habitrol's products are used by adult smokers in the United States who are trying to quit or reduce their smoking through nicotine replacement therapy.
Sources: Habitrol official site
Habitrol scores 41/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Habitrol has a limited AI-visibility profile at 41/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (57/100) and its weakest is trust (28/100). It benefits from a recognised Wikipedia company entity, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no strong Wikidata entry. In a live check, Claude could already identify Habitrol from memory (November 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Habitrol: Habion (81/100), Guts UK (81/100), Hackensack Meridian Health (81/100), Halma (81/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.